Meta AnalysisID 6444
中成药治疗高脂血症：随机对照试验的网状Meta分析
CRD42017062739
Which Chinese patent medicine is the most effective for people with hyperlipidemias?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6444
- Evidence Id
- 15002
- Core Evidence Id
- 15002
- Source Meta Analysis Id
- 6427
- Herb2 Meta Analysis Id
- HBMA006427
- Crd Id
- CRD42017062739
- Title
- Chinese patent medicine for hyperlipidemias: a network meta-analysis of randomized controlled trials
- Review Question
- Which Chinese patent medicine is the most effective for people with hyperlipidemias?
- Study Type Included
- Randomized controlled trials will be included.
- Condition Being Studied
- Hyperlipidemias, including hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia.
- Participant
- People diagnosed primary hyperlipidemias, with or without combined disease, no limit about age, gender.
- Animal
- Human Disease Modelled
- Intervention
- Chinese patent medicine,including Xuezhikang Capsule, Zhibituo Capsule, Jiangzhiling, compound Danshen dropping pills, Tongxinluo Capsule and Ginkgobilobaextract or the combination with other Chinese patent medicine or Western medicine.
- Comparator Control
- Treatment classes and individual treatments were compared versus every other using a class-model network meta-analysis.
- Main Outcome
- 1. Cardiovascular events 2. Serum lipid levels (including TG,TC, LDL-C and HDL-C). Measures of effect 1. both fatal and non-fatal events, including myocardial infarction, angina pectoris, stroke (any stroke, hemorrhagic and non-hemorrhagic) peripheral arterial disease, sudden death were regarded as cardiovascular events; 2. The numerical values will be extracted.
- Outcome Measure
- Additional Outcome
- 1. Effective rate 2. Adverse events 3. Symtoms of Chinese medicine Measures of effect According to the information offered by the trials, we will abstract the related data.
- Study Method
- Network meta-analysis, Systematic review
- Keyword
- Humans; Hyperlipidemias; Medicine, Chinese Traditional; Network Meta-Analysis; Nonprescription Drugs; Randomized Controlled Trials as Topic
- Contact
- Professor Wen [email protected]
- Organisational Affiliation
- guangzhou university of chinese medicine http://yjsy.bm.gzucm.edu.cn/
- Funding Source
- This work received a grant from the National Key Technology R&D Program for the 12th Five-year Plan of Ministry of Science and Technology, China (No. 2013BAI02B10) and he Specialized Research Subject of Guangdong Provincial Hospital of Chinese Medicine(YN2015MS14).
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English, Chinese-HK
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- Registration Date
- 2017-04-14
- Anticipated Start Date
- 2017-03-01
- Anticipated Completion Date
- 2017-12-31
- Title Cn
- 中成药治疗高脂血症：随机对照试验的网状Meta分析
- Title En
- Chinese patent medicine for hyperlipidemias: a network meta-analysis of randomized controlled trials
- Bilingual Status
- complete